Gentry E J, Jampani H B, Keshavarz-Shokri A, Morton M D, Velde D V, Telikepalli H, Mitscher L A, Shawar R, Humble D, Baker W
PathoGenesis Corporation, 201 Elliott Avenue West, Suite 150, Seattle, Washington 98119, USA.
J Nat Prod. 1998 Oct;61(10):1187-93. doi: 10.1021/np9701889.
Berberine (4) is responsible for the activity of an extract of a commercial root sample of Hydrastis canadensis against multiply drug resistant Mycobacterium tuberculosis. Two new quinic acid feruloyl esters, compounds 2 and 3, have been isolated from the same source along with canadine (1c), 8-oxotetrahydrothalifendine (1), and beta-hydrastine (5). These were found to be inactive. The structures of the new compounds were elucidated from spectral (1H, 13C, HMQC, HMBC, and H-H COSY) and chemical evidences.